Clinical Trials Logo

Acne clinical trials

View clinical trials related to Acne.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06043102 Active, not recruiting - Acne Clinical Trials

Study Evaluating the Efficacy and Safety of TheraClearX on Mitigating Mild to Moderate Acne

Start date: May 9, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to further substantiate the effectiveness and safety of TheraClearX as a stand-alone treatment of mild to moderate acne in healthy teenagers and adults ages 12-40 over the course of 7 weeks. Participants will be asked to have TheraClearX treatments weekly for 6 sessions, attend a follow up appointment 2 weeks after the 6th session, have photos taken of their face and answer questionnaires related to their acne.

NCT ID: NCT02704507 Active, not recruiting - Acne Clinical Trials

Addition of a Topical Steroid to a Topical Retinoid in Acne Patients

Start date: June 2015
Phase: N/A
Study type: Interventional

A randomized, split-face, placebo-controlled, double-blind, single-center clinical trial comparing topical retinoid on half the face and retinoid plus topical steroid on the other half.

NCT ID: NCT02695446 Active, not recruiting - Acne Clinical Trials

Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline

Start date: March 2016
Phase: Phase 4
Study type: Interventional

The primary objective of this study is to evaluate the skin and plasma concentrations of minocycline in subjects undergoing treatment of acne vulgaris with oral extended release minocycline. Acne lesion counts and safety/tolerance of the treatment will also be evaluated.

NCT ID: NCT01111994 Active, not recruiting - Acne Clinical Trials

Efficacy & Safety of Clindamycin and Tretinoin in Acne

Start date: November 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is ascertain the efficacy and safety of Clindamycin Phosphate 1.2% and Tretinoin 0.025% in the treatment of Acne and Post Inflammatory Hyperpigmentation in patients with skin of color.